Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

Fig. 2

ROC curve analysis and Kaplan–Meier survival analysis. a-d ROC curve analysis of the relationship between survival and PABPC1 (a), Ki-67 (b), p53 (c), and EBER1/2 expression (d), respectively. Only PABPC1 expression was significantly related to survival; (e–h) Kaplan–Meier survival analysis of the relationship between overall survival (OS) and PABPC1 (e), Ki-67 (f), p53 (g), and EBER1/2 expression (h), respectively; (i-l) Kaplan–Meier survival analysis of the relationship between disease-free survival (DFS) and PABPC1 (i), Ki-67 (j), p53 (k), and EBER1/2 expression (l), respectively. The OS and DFS of patients differed significantly between the high-expression and low-expression groups only for PABPC1

Back to article page